Stipple Bio
PrivateLast Round
Series A
Apr 6, 2026
Est. Valuation
$2.25B
Total Funding Raised
$121.46M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Stipple Bio is a biotechnology company that develops precision oncology therapies using its Pointillist platform to identify tumor-specific cell surface epitopes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stipple Bio Comparables
Compare Stipple Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TegMine Therapeutics | 77% | |
| Sidewinder Therapeutics | 76% | |
| Mersana Therapeutics | 74% |
Stipple Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 6, 2026 | ||||
| Seed | Dec 20, 2024 | ||||
| Seed | May 31, 2022 |
Stipple Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed, Series A |
| RA Capital Management | Series A |
| GV | Series A |
| GordonMD Global Investments | Series A |
| OMX Ventures | Seed |
| Emerson Collective | Seed, Series A |
| OMX Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Grew 31% QoQ, from 13 to 17 employees.
- Jun 26, 2026
Grew 86% QoQ, from 7 to 13 employees.
Recent news
Latest coverage and updates
- hiresJul 8, 2026
Stipple hired Roland Gendron as chief business officer on Jul 8th '26.
Stipple Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stipple Bio's valuation, stock price, and market status.
Is Stipple Bio a public or private company?
Stipple Bio is a private company.
What is the current stock price of Stipple Bio?
Stipple Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Stipple Bio worth (valuation)?
Valuation information for Stipple Bio is not publicly available.
Can I buy Stipple Bio stock?
Stipple Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Stipple Bio's last funding round?
Stipple Bio's most recent funding round was Series A on April 6, 2026.
Who are the main investors in Stipple Bio?
Key investors in Stipple Bio include Andreessen Horowitz, RA Capital Management, Nextech Invest.
Will Stipple Bio IPO soon?
No public IPO plans have been announced for Stipple Bio.
How can I track Stipple Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stipple Bio's secondary market activity and sign up for updates.